Indefinite Delivery Contract 75N93019D00016
Award Date 1/11/19
Last Date to Order 1/14/26
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a multiple award indefinite delivery contract to the American Type Culture Collection for in vitro assessments of antimicrobial activity and related biological products and services. The master contract has a potential value of $30 million over its period of performance from January 2019 to January 2026. Two task orders have been issued against the contract to date. A $3.08 million order was awarded...
- Southern Research Institute, a non-profit biomedical research organization based in Birmingham, Alabama, was awarded a single-award Indefinite Delivery Contract by the National Institute of Allergy and Infectious Diseases (NIAID) on September 15, 2025, with a ceiling value of $50,000,000 and an ultimate completion date of September 14, 2032. The contract procures Interventional Agents Safety and Pharmacokinetic Services, encompassing specialized scientific research and development activities...
- The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a multiple award indefinite delivery contract with a potential value of $30 million to Colorado State University Sponsored Programs Division. The contract is for in vitro assessments of antimicrobial activity to support the agency's mission of conducting and supporting research on infectious and immune-mediated diseases. Colorado State University was issued a $2,500 delivery order against this...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a single-award Indefinite Delivery Contract (IDC) worth up to $146.3M to the University of South Alabama to provide pre-clinical models of infectious diseases. The contract has a 7-year ordering period ending on July 14, 2031. The IDC comprises four task areas focused on developing and refining small animal, non-human primate, and non-traditional/animal replacement models to evaluate candidate countermeasures (e.g....
- This indefinite delivery contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the Southern Research Institute, a non-profit research organization located in Birmingham, Alabama. The contract has a ceiling value of $136,588,701.00 and a period of performance from September 30, 2025 to September 29, 2035. The purpose of this contract is to provide "EVALUATION AND TESTING SERVICES (ETS) FOR VACCINES AND OTHER BIOLOGICS FOR...
- The In Vitro Assessments of Antimicrobial Activity (IVAAA) master indefinite-delivery/indefinite-quantity contract was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide research services assessing the antimicrobial activity of substances against infectious agents. The University of Texas Health Science Center of San Antonio is the prime contractor for this multiple award contract vehicle with a potential value of $30 million and a...
- Southern Research Institute, a non-profit research organization based in Birmingham, Alabama, was awarded a single-award Indefinite Delivery Contract by the National Institute of Allergy and Infectious Diseases (NIAID) with a ceiling value of $255.8 million. The contract was awarded on September 15, 2003, with an ultimate completion date of December 11, 2015. The contract supports research and development in the physical, engineering, and life sciences, with all work performed at Southern...
- The National Institute of Allergy and Infectious Diseases has awarded an indefinite delivery contract with a potential value of $107,274,471 to multiple prime contractors to provide preclinical development support for candidate products and drug development activities ranging from initial product discovery to activities required for clinical trials and product licensure. Task orders will be issued under seven task areas, including in vitro testing, synthesis of therapeutic agents, small animal...
- The National Institute of Allergy and Infectious Diseases awarded an indefinite delivery contract to FHI Clinical Inc. to provide comprehensive and rapid response research programs. The contract has a potential value of $545,452,906 over a seven-year ordering period through August 2028. Two task orders have been issued against it to date, one for $332,178 and another for $2,000. Under the contract, FHI Clinical Inc. will support the NIAID's mission to conduct biomedical research on infectious,...
- The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded an indefinite-delivery/indefinite-quantity contract to Bioqual, Inc. valued at $545 million with a period of performance from September 2021 to August 2028. Task orders issued against the contract include a $2,000 firm fixed price order to Bioqual for comprehensive and rapid response services in Bethesda, Maryland from September 2021 to August 2022. The original solicitation sought proposals for a...
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order 75N93019D00016-75N93023F00001 | University Of Alabama At Birmingham | $548.8k | 9/5/23 | 9/4/24 | 2/9/24 | |
Delivery Order 75N93019D00016-75N93021F00001 | University Of Alabama At Birmingham | $595.2k | 8/16/21 | 8/15/22 | 3/23/22 | |
Delivery Order 75N93019D00016-75N93025F00001 | University Of Alabama At Birmingham | $560.4k | 12/16/24 | 12/15/25 | 11/26/25 | |
Delivery Order 75N93019D00016-75N93019F00131 | University Of Alabama At Birmingham | $499.8k | 1/11/19 | 7/25/20 | 11/13/19 | |
Delivery Order 75N93019D00016-75N93022F00001 | University Of Alabama At Birmingham | $616.4k | 8/29/22 | 8/28/23 | 8/3/22 |